By Rishika Sadam March 11 (Reuters) - India's drug regulator has warned pharmaceutical companies against direct or indirect advertising of weight-loss medicines, including obesity awareness campaigns ...

March 3 (Reuters) - The U.S. Food and Drug Administration has warned Novo Nordisk over a consumer ad for its blockbuster ...

It's rare to make it through an episode of your favorite show without seeing a commercial for a prescription drug that ...

Food and Drug Administration has issued warning letters to 30 telehealth companies for making false or misleading ‌claims ...

Aging means “becoming a target” of the industry, one expert said. After decades of debate, politicians of all stripes are proposing bans.

India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates ...

FDA sends Novo Nordisk 2nd warning over GLP-1 ads for misleading claims in Ozempic promotion and risk disclosure violations.

CDSCO warned that any form of advertisement -- direct or indirect -- promoting such medicines to the general public could ...

TrumpRx is primarily for people who pay for their prescriptions out-of-pocket. There may be cheaper generic options at direct ...

The Drugs Controller General of India (DCGI) has issued strict warning against promotional activities, including “awareness campaigns," that functions as a surrogate advertisement for ...

Food and Drug Administration ‌has told Novo Nordisk ‌to stop running a consumer ad ​for its blockbuster diabetes drug Ozempic, saying the commercial makes false and misleading claims ‌about what ⁠the ...

Food ‌and Drug Administration ‌has told Novo Nordisk ​to stop running a consumer ad for its blockbuster ‌diabetes ⁠drug Ozempic, saying the commercial ⁠makes false and misleading claims ​about what ...